Does Wegovy Give You Constipation? What the Clinical Evidence Shows

What the STEP trial data actually recorded about constipation

The STEP 1 trial, published in the New England Journal of Medicine, was the largest of the semaglutide weight-management studies, running for 68 weeks with adults who had obesity or overweight with at least one weight-related condition. If you have been wondering does Wegovy constipate you, the trial data offers a clear starting point: constipation appeared as one of the gastrointestinal events in the semaglutide group. The NHS lists constipation explicitly under the known side effects of semaglutide on its semaglutide medicines page, alongside nausea, vomiting, diarrhoea and reflux. It sits in the category of effects that are common but not universal — a number of participants experienced it, a larger number did not.

One pattern the trial data reflects is timing. Gastrointestinal effects, including constipation, cluster around the period after starting treatment and again after each dose increase, when the body is still adjusting. Many people find the symptom lessens as they settle into a stable dose. That said, some people experience constipation intermittently throughout treatment, and a smaller group find it more persistent. Neither outcome is unusual, and both are worth mentioning to your prescriber rather than managing in silence.

The broader Wegovy clinical programme consistently showed that gastrointestinal effects were the most commonly reported class of side effect. Our Wegovy constipation guide explores how frequently this is reported and what the regulatory summaries say about it in more detail.

Why semaglutide affects bowel habits: the mechanism behind the symptom

Semaglutide activates GLP-1 receptors across several systems simultaneously. The weight-loss effect depends partly on slowed gastric emptying, which prolongs the feeling of fullness and reduces appetite. The same mechanism, applied further down the digestive tract, reduces the speed at which intestinal contents move along. When transit slows, more water is absorbed from stool, which leaves it firmer and harder to pass. That is constipation, in straightforward physiological terms.

Reduced food intake compounds the picture. People on Wegovy typically eat significantly less, which means less dietary fibre reaching the bowel and smaller stool volume — both of which make constipation more likely regardless of any direct drug effect. Dehydration is a related factor: nausea in the early weeks can reduce the desire to drink, and even mild dehydration has a noticeable effect on stool consistency.

Understanding the mechanism matters because it points directly at the management strategies that work: keeping fibre intake up even when appetite is suppressed, drinking enough fluid throughout the day, and staying physically active where possible. Our prescribers field this question most weeks, and the answer is almost always the same, small, consistent adjustments to diet and hydration usually make a real difference. For more detail on adjusting diet alongside treatment, the full guide to Wegovy side effects covers this in context.

Practical steps that can help, and what to discuss with your prescriber

The guidance on managing constipation during semaglutide treatment is practical rather than complicated. Prioritise fluid, water primarily, with regular sips across the day rather than large volumes at once. Keep fibre-containing foods in your diet even as portion sizes fall; vegetables, wholegrains, pulses and fruit all contribute. Gentle movement such as walking has a well-established effect on bowel motility and is particularly relevant on GLP-1 treatment, where reduced calorie intake might otherwise tempt more sedentary days.

If dietary measures are not sufficient, your prescriber or pharmacist can advise on whether an over-the-counter osmotic laxative is appropriate alongside Wegovy. That is a conversation worth having directly, self-selecting stimulant laxatives without guidance is not always the right first step, and your prescriber will want to know the symptom is ongoing. You can read about managing constipation on Wegovy in more detail, and if you are also dealing with nausea alongside it, the practical advice on handling nausea on Wegovy covers both symptoms in tandem.

Never adjust your dose timing or skip doses to try to manage a side effect. The titration schedule exists for good clinical reasons, and any change belongs in a conversation with your prescriber. If constipation is making you consider stopping treatment, say so, a prescriber can often help find a manageable path before discontinuation becomes necessary.

When constipation needs medical attention

Most constipation on Wegovy is uncomfortable but not dangerous. There are circumstances where it needs prompt medical review. Our page on whether Wegovy causes constipation outlines the warning signs that distinguish routine discomfort from symptoms requiring medical attention, including what to do if you have not had a bowel movement for more than a week, if there is significant abdominal pain or bloating alongside constipation, or if you notice any blood in your stool. Severe abdominal pain that radiates to the back, with or without vomiting, should be treated as urgent: the MHRA highlighted acute pancreatitis as a rare but serious risk with GLP-1 medicines in a safety update, and severe upper-abdominal pain is not a symptom to observe at home.

If you develop signs of significant dehydration (dizziness, very dark urine, feeling faint) as a result of reduced fluid intake or concurrent nausea, that also warrants medical attention. Kidney function can be affected by sustained dehydration on GLP-1 treatment.

Any side effect you suspect is related to Wegovy can be reported directly to the MHRA via the Yellow Card scheme. Patient reports contribute to ongoing monitoring of the medicine's safety profile, and reporting is straightforward at yellowcard.mhra.gov.uk. If you would like your current experience reviewed by a prescriber, our team at nume's aftercare service is available seven days a week. Alternatively, if you are considering starting Wegovy and want to understand what to expect, start your free consultation and our prescribers will discuss suitability and side effects with you directly before any prescription is issued.